CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Mehra Anand Director | Option exercise | +11,580 | 726,403 | ||
| 2026-06-05 | Mehra Anand Director | Option exercise · Restricted Stock Units | −11,580 | 0 | ||
| 2026-06-04 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2026-06-04 | Mehra Anand Director | Grant or award · Restricted Stock Units | +10,987 | 10,987 | ||
| 2025-06-06 | Mehra Anand Director | Option exercise | +4,793 | 714,823 | ||
| 2025-06-06 | Mehra Anand Director | Option exercise · Restricted Stock Units | −4,793 | 0 | ||
| 2025-06-05 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | Mehra Anand Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2024-11-19 | Mehra Anand Director | Purchase | +666,666 | $2.25 | $1.5M | 710,030 |
| 2024-06-06 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2024-06-06 | Mehra Anand Director | Grant or award · Restricted Stock Units | +4,793 | 4,793 | ||
| 2024-06-01 | Mehra Anand Director | Option exercise | +4,660 | 43,364 | ||
| 2024-06-01 | Mehra Anand Director | Option exercise · Restricted Stock Units | −4,660 | 0 | ||
| 2023-06-02 | Mehra Anand Director | Option exercise | +4,507 | 38,704 | ||
| 2023-06-02 | Mehra Anand Director | Option exercise · Restricted Stock Units | −4,507 | 0 | ||
| 2023-06-01 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Mehra Anand Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2022-06-03 | Mehra Anand Director | Option exercise | +3,356 | 34,197 | ||
| 2022-06-03 | Mehra Anand Director | Option exercise · Restricted Stock Units | −3,356 | 0 | ||
| 2022-06-02 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 |
Page 1 of 3 · 44 trades